| Financial Year |
March 31 2023 |
| Monetary Funds |
106,860,187.09 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,758,040.15 |
| Accounts Receivable |
279,840,158.46 |
| Advances to Suppliers |
58,940,659.16 |
| Other Receivables |
17,162,834.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
52,841,680.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,383,555.74 |
| Total Current Assets |
540,787,115.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
102,885,668.74 |
| Investment Properties |
645,106,614.60 |
| Fixed Assetes |
1,158,545,209.65 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
744,867,159.11 |
| R&D expenses |
132,419,106.07 |
| Goodwill |
688,074,652.05 |
| Long-Term Deferred and Prepaid Expenses |
39,447,701.85 |
| Deferred Income Tax Assets |
307,812,151.91 |
| Other Non-Current Assets |
610,874.30 |
| Sub-Total of Non-Current Assets |
3,888,049,999.78 |
| Total Assets |
4,428,837,115.64 |
| Short-Term Loans |
768,760,875.03 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
332,978,947.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
135,752,297.32 |
| Taxes Payable |
24,584,381.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
228,854,560.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
82,785,966.64 |
| Other Current Liabilities |
13,037,180.36 |
| Sub-Total of Current Liabilities |
1,685,346,692.23 |
| Long-term Loans |
705,496,693.88 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
5,273,074.22 |
| Special Payable |
-- |
| Estimatied Liabilities |
944,235.25 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
206,655,959.18 |
| Sub-Total of Non-Current Liabilities |
928,029,371.21 |
| Total Liabilities |
2,613,376,063.44 |
| Paid-In Capital(Or Share Stock) |
1,244,198,401.00 |
| Capital Surplus |
53,030,751.03 |
| Surplus Reserve |
50,380,914.20 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
515,693,544.24 |
| Minority Stockholder's Interest |
-855,956.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,816,317,008.54 |
| Owner's Equity（Stockholder's Equity） |
1,815,461,052.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,428,837,115.64 |
